EV/EBITDA
19.41
+0.81+4.35%
Thu, 02 Jan 2025 22:52:56 GMT
Summary:
Voyager Therapeutics EV/EBITDA is currently 19.41, with a rise of +0.81 (+4.35%) during the most recent trading day. Over the past year, it has increased by +16.60 (+590.75%). VYGR EV/EBITDA is now -27.00% below its all-time high of 26.59.VYGR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYGR EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +4.3% |
| 1 m1 month | -11.8% |
| 3 m3 months | +9.3% |
| 6 m6 months | +109.0% |
| ytdytd | +4.3% |
| 1 y1 year | +590.8% |
| 5 y5 years | +311.7% |
VYGR EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 22.00 | -11.8% | 16.86 | +15.1% |
| 3 m | 3 months | 26.59 | -27.0% | 16.24 | +19.5% |
| 6 m | 6 months | 26.59 | -27.0% | -269.13 | +107.2% |
| 1 y | 1 year | 26.59 | -27.0% | -269.13 | +107.2% |
| 3 y | 3 years | 26.59 | -27.0% | -269.13 | +107.2% |
| 5 y | 5 years | 26.59 | -27.0% | -269.13 | +107.2% |
| alltime | all time | 26.59 | -27.0% | -269.13 | +107.2% |
Voyager Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 19.41(+4.4%) |
| 2024 | 18.60(+626.6%) |
| 2023 | 2.56(-176.6%) |
| 2022 | -3.34(+676.7%) |
| 2021 | -0.43(-106.4%) |
| Date | Value |
|---|---|
| 2020 | 6.74(-171.3%) |
| 2019 | -9.45(+227.0%) |
| 2018 | -2.89(-58.8%) |
| 2017 | -7.01(-1.4%) |
| 2016 | -7.11(-72.9%) |
| 2015 | -26.19 |
FAQ
- What is Voyager Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Voyager Therapeutics?
- What is VYGR EV/EBITDA year-to-date change?
- What is Voyager Therapeutics EV/EBITDA year-on-year change?
What is Voyager Therapeutics EV/EBITDA?
The current EV/EBITDA of VYGR is 19.41
What is the all time high EV/EBITDA for Voyager Therapeutics?
Voyager Therapeutics all-time high EV/EBITDA is 26.59
What is VYGR EV/EBITDA year-to-date change?
Voyager Therapeutics EV/EBITDA has changed by +0.81 (+4.35%) since the beginning of the year
What is Voyager Therapeutics EV/EBITDA year-on-year change?
Over the past year, VYGR EV/EBITDA has changed by +16.60 (+590.75%)